The global Apheresis Market was valued at USD 2.9 billion in 2023 and is projected to reach USD 6.7 billion by the end of 2034. The market is expected to expand at a CAGR of 7.7% from 2024 to 2034, driven by the rising prevalence of chronic and blood-related disorders, growing demand for plasma-derived therapies, and increasing adoption of advanced apheresis technologies in hospitals and blood collection centers worldwide.

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=896

Raw material security and the efficiency of separation technologies play a critical role. For medical device manufacturers, maintaining a steady supply of high-quality disposables is essential as procedure volumes increase. Beyond traditional centrifugation, other technologies are being refined, including membrane filtration and selective adsorption. Increasing demand for specialized blood components is driving the need for automated systems that minimize procedure time and maximize component purity.

With the advancement of biotechnology and automated software, apheresis systems with improved process control and real-time monitoring have been developed. To meet specific clinical challenges, innovations such as extracorporeal photopheresis (ECP) for graft-versus-host disease and LDL apheresis for severe cholesterol disorders have been introduced. The rising incidence of autoimmune and neurological conditions has prompted the development of protocols that target specific pathogenic substances in the plasma.

Next-generation apheresis may be possible with AI-integrated systems and portable, point-of-care devices. In addition to streamlining hospital workflows, these advancements aim to move treatment into decentralized and outpatient settings. As the regenerative medicine sector expands, research is focused on optimizing leukapheresis for the collection of high-quality starting materials for CAR-T therapies. The transition toward a more integrated digital health ecosystem is driven by the need for seamless data tracking from donation to final therapeutic product.

Key Findings of the Market Report

• Based on product, the disposables and reagents segment dominated the market in 2024, accounting for approximately 70% of total revenue due to high recurrent usage.
• A greater emphasis on leukapheresis is likely to create high-growth opportunities, specifically as a preparatory step for advanced oncology treatments.
• North America held the largest market share in 2025, supported by a mature cell and gene therapy ecosystem and high healthcare expenditure.
• The Asia-Pacific region is projected to be the fastest-growing market, driven by expanding healthcare infrastructure and rising awareness of blood donation benefits.

Global Apheresis Market: Growth Drivers

• Expansion of Cell & Gene Therapies: The surge in FDA-approved CAR-T and gene therapies requires standardized leukapheresis for consistent cell collection.
• Rising Prevalence of Chronic Diseases: Increasing cases of leukemia, lymphoma, and autoimmune disorders (like Myasthenia Gravis) necessitate frequent therapeutic apheresis.
• Technological Advancements: Integration of Artificial Intelligence (AI) and advanced automation reduces manual intervention and improves separation precision.
• Demand for Plasma-Derived Products: Growing requirements for immunoglobulins and clotting factors drive the expansion of plasma collection networks globally.
• Supportive Government Policies: Favorable reimbursement frameworks in developed nations and national "plasma self-sufficiency" initiatives in emerging markets.

Global Apheresis Market: Regional Landscape

• North America continues to lead the market, with the U.S. alone requiring approximately 29,000 units of red blood cells daily. The region’s dominance is underpinned by significant R&D investment and a dense network of specialized transfusion centers.
• Asia-Pacific is expected to experience rapid growth, with a projected CAGR of over 8%. Rapidly modernizing healthcare systems in China and India, coupled with government initiatives to promote blood donation, are positioning the region as a primary growth driver for global equipment manufacturers.

Global Apheresis Market: Key Players

Major apheresis manufacturers are utilizing equipment-as-a-service models and strategic partnerships to expand their global footprint.

• Fresenius Kabi AG
• Terumo BCT, Inc. (Terumo Corporation)
• Haemonetics Corporation
• Asahi Kasei Medical Co., Ltd.
• B. Braun SE
• Baxter International Inc.
• Cerus Corporation
• Kaneka Corporation
• Nikkiso Europe GmbH
• Mallinckrodt plc

Key Developments

• In August 2022, Haemonetics Corporation, a global healthcare company, announced an agreement with Epic, a leading HER system provider, to offer Haemonetics’ SafeTrace Tx blood bank information system to Epic’s network hospitals globally.
• In July 2022, Terumo Corporation, one of the world's leading manufacturers of medical devices and supplies, collaborated with Eliaz Therapeutics, a developer of novel treatment using targeted therapeutic apheresis, to develop and commercialize a novel therapeutic apheresis treatment for Acute Kidney Injury (AKI).

Buy this Premium Research Report:  https://www.transparencymarketresearch.com/checkout.php?rep_id=896&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com     
Email: sales@transparencymarketresearch.com